A company's volume growth in India is being offset by the divestiture of its sales.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company's volume growth in India is being offset by the divestiture of its sales.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer Inc. is discontinuing product sales in India and providing lump sum payments for the discontinuation.Sub-event
Divestiture of India sales is offsetting volume growth for an unnamed company.1 source
Keep exploring
The entities involved
Related events
- Global production volumes are fluctuating in global markets.
- India is poised to outperform global market trends.
- Tata Motors Commercial Vehicles Limited is experiencing growth driven by volumes and new product launches in India.
- Indian companies, including Airtel Africa and Sun Pharma, are leveraging their market strength to pursue outbound deals and expand globally.
- Mahindra Group is undergoing strategic shifts led by Anand Mahindra, utilizing India for manufacturing and growth.